Proton beam therapy continues to generate significant interest — and controversy — in prostate cancer. About 45 cancer centers in the US offer proton therapy to treat a variety of cancers, including ...

A 64-year-old long-distance runner, Todd Elworthy was alarmed and confused when his routine prostate specific antigen (PSA) test was elevated in 2023, and a biopsy came back positive for prostate ...

Patient-reported quality of life (QoL) was similar between proton beam therapy (PBT) and intensity-modulated radiation therapy (IMRT) among men with localized prostate cancer, the randomized PARTIQoL ...

People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy—proton beam therapy or intensity modulated radiation therapy (IMRT)—achieved ...

People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy - proton beam therapy or intensity modulated radiation therapy (IMRT) - ...

Please provide your email address to receive an email when new articles are posted on . Men with low- or intermediate-risk prostate cancer achieved similar quality-of-life outcomes whether they ...

HONG KONG, July 7, 2026 /PRNewswire/ -- The HKSH Cancer Centre under HKSH Medical Group (HKSH) introduced proton therapy in 2023, covering a wide range of cancer types including breast, prostate as ...

SOMERSET, N.J., Feb. 13, 2026 /PRNewswire/ -- In recognition of National Cancer Prevention Month, ProCure Proton Therapy Center is urging men to prioritize prostate-specific antigen (PSA) ...

When Shannon Fleming was told his prostate cancer had returned and was considered incurable, he says his world stopped."It ...

SOMERSET, N.J., June 12, 2026 /PRNewswire/ -- When Joseph, a military veteran diagnosed with prostate cancer, became ProCure Proton Therapy Center's 8,000th patient, the milestone represented far more ...

Proton beam therapy does not improve the patient-reported outcome of bowel function compared with IMRT. Bowel side effects do not differ between patients with localized prostate cancer who receive ...